Which hedge funds own HOWL? WEREWOLF THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
13 tracked hedge funds disclosed a position in HOWL (WEREWOLF THERAPEUTICS INC) in their Q2 2026 13F filings, worth $2.5m in total. The largest holder by portfolio weight is Verdad Advisers, LP at 0.1% of its book. 5 opened a new position this quarter: Rangeley Capital, LLC, Balyasny Asset Management L.P., Gsa Capital Partners LLP, Squarepoint Ops LLC. 2 exited: Squadron Capital Management LLC, Citadel Advisors LLC.
13
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
5
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
2
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$737k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$478k
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$2.5m
Combined value
Sum of the holders' reported positions in the security.
1.0%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.